Eosinophil Levels in Blood of COVID-19 Patient’s VS Seasonal Allergy

Taha Luqman Bilgrami; Hira Saleem

doi:doi:10.11648/j.iji.20221001.13

| Peer-Reviewed

Eosinophil Levels in Blood of COVID-19 Patient’s VS Seasonal Allergy

Taha Luqman Bilgrami, Hira Saleem

Published in International Journal of Immunology (Volume 10, Issue 1)

Received: 23 April 2022 Accepted: 20 May 2022 Published: 31 May 2022

Views: Downloads:

Download PDF

Share This Article

Twitter
Linked In
Facebook

Abstract

Eosinophilia, a peripheral blood with eosinophil count of more than 450 cells per microliter has been linked to allergies, medication responses, among others. However, the reduction in eosinophil levels has been particularly found to be having linkage with SARS-CoV-2 infection. This study aims at comparing COVID-19 patients' peripheral blood eosinophil levels to seasonal allergy patients' eosinophil counts to determine whether there is a link between eosinophil numbers and COVID-19 disease severity. Data was obtained from the review of the electronic medical records of 300 confirmed COVID-19 patients, alongside their clinical features were obtained. Data collected was then subjected to retrospective cohort analysis. Eosinopenia was found in 73.7 percent, 86.7 percent, and 94.3 percent of patients in the mild, moderate, and severe categories, respectively (p value 0.002). When compared to patients with moderate and severe illnesses, patients with critical disease had significantly lower eosinophil levels. Results from this study shows that increase in COVID-19 severity is associated with a significant drop in peripheral eosinophil levels, and that eosinopenia was present in the majority of COVID-19 patients. Seasonal allergic rhinitis is indicated as a particularly good model for studying the potential pathogenic effects of eosinophils and eosinophilic inflammation.

Published in	International Journal of Immunology (Volume 10, Issue 1)
DOI	10.11648/j.iji.20221001.13
Page(s)	11-14
Creative Commons	This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited.
Copyright	Copyright © The Author(s), 2024. Published by Science Publishing Group

Keywords

Eosinophil Levels, COVID-19, Immunity, Allergy

References

[1]	Du, M., et al. Lifelong anomaly detection through unlearning. in Proceedings of the 2019 ACM SIGSAC Conference on Computer and Communications Security. 2019.
[2]	Jain, H., R. Oak, and J. Bansal. Towards Developing a Secure and Robust Solution for E-Voting using Blockchain. in 2019 International Conference on Nascent Technologies in Engineering (ICNTE). 2019. IEEE.
[3]	Jhala, K. S., R. Oak, and M. Khare. Smart collaboration mechanism using blockchain technology. in 2018 5th IEEE International Conference on Cyber Security and Cloud Computing (CSCloud)/2018 4th IEEE International Conference on Edge Computing and Scalable Cloud (EdgeCom). 2018. IEEE.
[4]	Khare, M. and R. Oak, Real-Time distributed denial-of-service (DDoS) attack detection using decision trees for server performance maintenance, in Performance Management of Integrated Systems and its Applications in Software Engineering. 2020, Springer. p. 1-9.
[5]	Newman, J. C. and R. Oak, Artificial Intelligence: Ethics in Practice. login Usenix Mag., 2020. 45 (1).
[6]	Oak, R., A study of digital image segmentation techniques. Int. J. Eng. Comput. Sci, 2016. 5 (12): p. 19779-19783.
[7]	Oak, R., Extractive techniques for automatic document summarization: a survey. International Journal of Innovative Research in Computer and Communication Engineering, 2016. 4 (3): p. 4158-4164.
[8]	Oak, R., A literature survey on authentication using Behavioural biometric techniques. Intelligent Computing and Information and Communication, 2018: p. 173-181.
[9]	Oak, R. Poster: Adversarial Examples for Hate Speech Classifiers. in Proceedings of the 2019 ACM SIGSAC Conference on Computer and Communications Security. 2019.
[10]	Oak, R. and M. Khare. A novel architecture for continuous authentication using behavioural biometrics. in 2017 International Conference on Current Trends in Computer, Electrical, Electronics and Communication (CTCEEC). 2017. IEEE.
[11]	Oak, R., C. Rahalkar, and D. Gujar. Poster: Using generative adversarial networks for secure pseudorandom number generation. in Proceedings of the 2019 ACM SIGSAC Conference on Computer and Communications Security. 2019.
[12]	Oak, R., The Fault in the Stars: Understanding the Underground Market of Amazon Reviews. arXiv preprint arXiv: 2102.04217, 2021.
[13]	Oak, R., et al. Malware detection on highly imbalanced data through sequence modeling. in Proceedings of the 12th ACM Workshop on artificial intelligence and security. 2019.
[14]	Sehwag, V., et al., Time for a Background Check! Uncovering the impact of Background Features on Deep Neural Networks. arXiv preprint arXiv: 2006.14077, 2020.

Cite This Article

Plain Text BibTeX RIS

APA Style

Taha Luqman Bilgrami, Hira Saleem. (2022). Eosinophil Levels in Blood of COVID-19 Patient’s VS Seasonal Allergy. International Journal of Immunology, 10(1), 11-14. https://doi.org/10.11648/j.iji.20221001.13

Copy | Download

ACS Style

Taha Luqman Bilgrami; Hira Saleem. Eosinophil Levels in Blood of COVID-19 Patient’s VS Seasonal Allergy. Int. J. Immunol. 2022, 10(1), 11-14. doi: 10.11648/j.iji.20221001.13

Copy | Download

AMA Style

Taha Luqman Bilgrami, Hira Saleem. Eosinophil Levels in Blood of COVID-19 Patient’s VS Seasonal Allergy. Int J Immunol. 2022;10(1):11-14. doi: 10.11648/j.iji.20221001.13

Copy | Download

@article{10.11648/j.iji.20221001.13,
  author = {Taha Luqman Bilgrami and Hira Saleem},
  title = {Eosinophil Levels in Blood of COVID-19 Patient’s VS Seasonal Allergy},
  journal = {International Journal of Immunology},
  volume = {10},
  number = {1},
  pages = {11-14},
  doi = {10.11648/j.iji.20221001.13},
  url = {https://doi.org/10.11648/j.iji.20221001.13},
  eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.iji.20221001.13},
  abstract = {Eosinophilia, a peripheral blood with eosinophil count of more than 450 cells per microliter has been linked to allergies, medication responses, among others. However, the reduction in eosinophil levels has been particularly found to be having linkage with SARS-CoV-2 infection. This study aims at comparing COVID-19 patients' peripheral blood eosinophil levels to seasonal allergy patients' eosinophil counts to determine whether there is a link between eosinophil numbers and COVID-19 disease severity. Data was obtained from the review of the electronic medical records of 300 confirmed COVID-19 patients, alongside their clinical features were obtained. Data collected was then subjected to retrospective cohort analysis. Eosinopenia was found in 73.7 percent, 86.7 percent, and 94.3 percent of patients in the mild, moderate, and severe categories, respectively (p value 0.002). When compared to patients with moderate and severe illnesses, patients with critical disease had significantly lower eosinophil levels. Results from this study shows that increase in COVID-19 severity is associated with a significant drop in peripheral eosinophil levels, and that eosinopenia was present in the majority of COVID-19 patients. Seasonal allergic rhinitis is indicated as a particularly good model for studying the potential pathogenic effects of eosinophils and eosinophilic inflammation.},
 year = {2022}
}

Copy | Download

TY  - JOUR
T1  - Eosinophil Levels in Blood of COVID-19 Patient’s VS Seasonal Allergy
AU  - Taha Luqman Bilgrami
AU  - Hira Saleem
Y1  - 2022/05/31
PY  - 2022
N1  - https://doi.org/10.11648/j.iji.20221001.13
DO  - 10.11648/j.iji.20221001.13
T2  - International Journal of Immunology
JF  - International Journal of Immunology
JO  - International Journal of Immunology
SP  - 11
EP  - 14
PB  - Science Publishing Group
SN  - 2329-1753
UR  - https://doi.org/10.11648/j.iji.20221001.13
AB  - Eosinophilia, a peripheral blood with eosinophil count of more than 450 cells per microliter has been linked to allergies, medication responses, among others. However, the reduction in eosinophil levels has been particularly found to be having linkage with SARS-CoV-2 infection. This study aims at comparing COVID-19 patients' peripheral blood eosinophil levels to seasonal allergy patients' eosinophil counts to determine whether there is a link between eosinophil numbers and COVID-19 disease severity. Data was obtained from the review of the electronic medical records of 300 confirmed COVID-19 patients, alongside their clinical features were obtained. Data collected was then subjected to retrospective cohort analysis. Eosinopenia was found in 73.7 percent, 86.7 percent, and 94.3 percent of patients in the mild, moderate, and severe categories, respectively (p value 0.002). When compared to patients with moderate and severe illnesses, patients with critical disease had significantly lower eosinophil levels. Results from this study shows that increase in COVID-19 severity is associated with a significant drop in peripheral eosinophil levels, and that eosinopenia was present in the majority of COVID-19 patients. Seasonal allergic rhinitis is indicated as a particularly good model for studying the potential pathogenic effects of eosinophils and eosinophilic inflammation.
VL  - 10
IS  - 1
ER  -

Copy | Download

Author Information

Taha Luqman Bilgrami

Department of Internal Medicine, University of Debrecen, Debrecen, Hungary
Hira Saleem

Department of Internal Medicine, Bahria University, Karachi, Pakistan

Download PDF

Sections

Plain Text BibTeX RIS

APA Style

Taha Luqman Bilgrami, Hira Saleem. (2022). Eosinophil Levels in Blood of COVID-19 Patient’s VS Seasonal Allergy. International Journal of Immunology, 10(1), 11-14. https://doi.org/10.11648/j.iji.20221001.13

Copy | Download

ACS Style

Taha Luqman Bilgrami; Hira Saleem. Eosinophil Levels in Blood of COVID-19 Patient’s VS Seasonal Allergy. Int. J. Immunol. 2022, 10(1), 11-14. doi: 10.11648/j.iji.20221001.13

Copy | Download

AMA Style

Taha Luqman Bilgrami, Hira Saleem. Eosinophil Levels in Blood of COVID-19 Patient’s VS Seasonal Allergy. Int J Immunol. 2022;10(1):11-14. doi: 10.11648/j.iji.20221001.13

Copy | Download

@article{10.11648/j.iji.20221001.13,
  author = {Taha Luqman Bilgrami and Hira Saleem},
  title = {Eosinophil Levels in Blood of COVID-19 Patient’s VS Seasonal Allergy},
  journal = {International Journal of Immunology},
  volume = {10},
  number = {1},
  pages = {11-14},
  doi = {10.11648/j.iji.20221001.13},
  url = {https://doi.org/10.11648/j.iji.20221001.13},
  eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.iji.20221001.13},
  abstract = {Eosinophilia, a peripheral blood with eosinophil count of more than 450 cells per microliter has been linked to allergies, medication responses, among others. However, the reduction in eosinophil levels has been particularly found to be having linkage with SARS-CoV-2 infection. This study aims at comparing COVID-19 patients' peripheral blood eosinophil levels to seasonal allergy patients' eosinophil counts to determine whether there is a link between eosinophil numbers and COVID-19 disease severity. Data was obtained from the review of the electronic medical records of 300 confirmed COVID-19 patients, alongside their clinical features were obtained. Data collected was then subjected to retrospective cohort analysis. Eosinopenia was found in 73.7 percent, 86.7 percent, and 94.3 percent of patients in the mild, moderate, and severe categories, respectively (p value 0.002). When compared to patients with moderate and severe illnesses, patients with critical disease had significantly lower eosinophil levels. Results from this study shows that increase in COVID-19 severity is associated with a significant drop in peripheral eosinophil levels, and that eosinopenia was present in the majority of COVID-19 patients. Seasonal allergic rhinitis is indicated as a particularly good model for studying the potential pathogenic effects of eosinophils and eosinophilic inflammation.},
 year = {2022}
}

Copy | Download

TY  - JOUR
T1  - Eosinophil Levels in Blood of COVID-19 Patient’s VS Seasonal Allergy
AU  - Taha Luqman Bilgrami
AU  - Hira Saleem
Y1  - 2022/05/31
PY  - 2022
N1  - https://doi.org/10.11648/j.iji.20221001.13
DO  - 10.11648/j.iji.20221001.13
T2  - International Journal of Immunology
JF  - International Journal of Immunology
JO  - International Journal of Immunology
SP  - 11
EP  - 14
PB  - Science Publishing Group
SN  - 2329-1753
UR  - https://doi.org/10.11648/j.iji.20221001.13
AB  - Eosinophilia, a peripheral blood with eosinophil count of more than 450 cells per microliter has been linked to allergies, medication responses, among others. However, the reduction in eosinophil levels has been particularly found to be having linkage with SARS-CoV-2 infection. This study aims at comparing COVID-19 patients' peripheral blood eosinophil levels to seasonal allergy patients' eosinophil counts to determine whether there is a link between eosinophil numbers and COVID-19 disease severity. Data was obtained from the review of the electronic medical records of 300 confirmed COVID-19 patients, alongside their clinical features were obtained. Data collected was then subjected to retrospective cohort analysis. Eosinopenia was found in 73.7 percent, 86.7 percent, and 94.3 percent of patients in the mild, moderate, and severe categories, respectively (p value 0.002). When compared to patients with moderate and severe illnesses, patients with critical disease had significantly lower eosinophil levels. Results from this study shows that increase in COVID-19 severity is associated with a significant drop in peripheral eosinophil levels, and that eosinopenia was present in the majority of COVID-19 patients. Seasonal allergic rhinitis is indicated as a particularly good model for studying the potential pathogenic effects of eosinophils and eosinophilic inflammation.
VL  - 10
IS  - 1
ER  -

Copy | Download